CAR T cells for treating autoimmune diseases Ulrich Blache, Sandy Tretbar, Ulrike Koehl, Dimitrios Mougiakakos, Stephan Fricke
14 February 2024
Long versus short-term opioid therapy for fibromyalgia syndrome and risk of depression, sleep disorders and suicidal ideation: a population-based, propensity-weighted cohort study Isabel Hurtado, Celia Robles, Salvador Peiró, Aníbal García-Sempere, Fran Llopis, Francisco Sánchez, Clara Rodríguez-Bernal, Gabriel Sanfélix
23 September 2024
Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease Johanna Bausson, Nicolas Keller, Jean-Jacques Von Hunolstein, Matthieu Sacrez, Bruno Michel, Bénédicte Gourieux, Marion Fourtage, Renaud Felten
31 January 2024
Low prevalence of anti-SSA (anti-Ro) and anti-SSB (anti-La) autoantibodies in female patients with rheumatoid arthritis with a wish to conceive Hieronymus T W Smeele, Marco W J Schreurs, Nathalie Costedoat-Chalumeau, Jerome M J Cornette, Radboud J E M Dolhain
11 January 2024
Association between sinusitis and incident rheumatic diseases: a population-based study Vanessa L Kronzer, John M Davis, Andrew C Hanson, Jeffrey A Sparks, Elena Myasoedova, Ali Duarte-Garcia, Alicia M Hinze, Ashima Makol, Mattew J Koster, Robert Vassallo, Kenneth J Warrington, Kerry Wright, Cynthia S Crowson
22 February 2024
Application of the OMERACT Grey-scale Ultrasound Scoring System for salivary glands in a single-centre cohort of patients with suspected Sjögren’s syndrome Viktoria Fana, Uffe M Dohn, Simon Krabbe, Lene Terslev
11 January 2024
Increased prevalence of hearing loss, tinnitus and sudden deafness among patients with Sjögren’s syndrome Tzong-Hann Yang, Sudha Xirasagar, Yen-Fu Cheng, Chin-Shyan Chen, Herng-Ching Lin
19 January 2024
Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223 526 participants Ling-Qiong Jiang, Ruo-Di Zhang, Harry Asena Musonye, Hao-Yun Zhao, Yi-Sheng He, Chan-Na Zhao, Tian He, Tian Tian, Zhao-Xing Gao, Yang Fang, Peng Wang, Jing Ni, Hai-Feng Pan
9 January 2024
Cryoneurolysis versus radiofrequency ablation outcome on pain experience in chronic low back pain (COPE): a single-blinded randomised controlled trial Kamilla Truong, Kaare Meier, Lasse Cramer Ahrens, Thea Overgaard Wichmann, Hamed Zaer, Lasse Hubertus Tiroke, Simon Arvin, Mindaugas Bazys, Peter Duel, Gudrun Gudmundsdottir, Jakob Gram Carlsen, Lone Nikolajsen, Maurits van Tulder, Jens Christian Hedemann Sørensen, Mikkel Mylius Rasmussen
9 May 2024
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL Laura C Coates, Robert Landewé, Iain B McInnes, Philip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana-Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan BajracharyaSee the full list of authors
22 February 2024
Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force Julien Blaess, Sophie Geneton, Thibaut Goepfert, Simone Appenzeller, Gabriel Bordier, Thomas Davergne, Yurilis Fuentes, Håvard Haglo, Karen Hambly, Dominique Kinnett-Hopkins, Kuei-Ying Su, Alexandra Legge, Linda Li, Anselm Mak, Ivan PadjenSee the full list of authors
4 April 2024
Twenty-year trajectories of morbidity in individuals with and without osteoarthritis Andrea Dell'Isola, Filippo Recenti, Martin Englund, Ali Kiadaliri
2 July 2024
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis Philip J Mease, Soumya Reddy, Sarah Ross, Jeffrey R Lisse, Paulo Reis, Kirstin Griffing, Christophe Sapin, Aisha Vadhariya, Daniel E Furst
31 January 2024
PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs Celine J van de Laar, Martijn A H Oude Voshaar, Peter ten Klooster, Danyta I Tedjo, Reinhard Bos, Tim Jansen, A Willemze, Grada A Versteeg, Y P M Goekoop-Ruiterman, Eric-Jan Kroot, Mart van de Laar
30 May 2024
Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis George Athanasios Karpouzas, Sarah R Ormseth, Piet Leonardus Cornelis Maria van Riel, Miguel A Gonzalez-Gay, Alfonso Corrales, Solbritt Rantapää-Dahlqvist, Petros P Sfikakis, Patrick Dessein, Linda Tsang, Carol Hitchon, Hani El-Gabalawy, Virginia Pascual-Ramos, Irazú Contreras-Yáñez, Iris J Colunga-Pedraza, Dionicio Angel Galarza-DelgadoSee the full list of authors
23 July 2024
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study Roy Fleischmann, Jerzy Swierkot, Sara K Penn, Patrick Durez, Louis Bessette, Xianwei Bu, Nasser Khan, Yihan Li, Charles G Peterfy, Yoshiya Tanaka, Eduardo Mysler
28 May 2024
Analysis of belimumab prescription and outcomes in a 10-year monocentric cohort: is there an advantage with early use? Chiara Tani, Dina Zucchi, Chiara Cardelli, Elena Elefante, Viola Signorini, Davide Schilirò, Giancarlo Cascarano, Luca Gualtieri, Anastasiya Valevich, Giulia Puccetti, Linda Carli, Chiara Stagnaro, Marta Mosca
12 April 2024
Impact of inflammation on cognitive function in patients with highly inflammatory rheumatoid arthritis Natalia Mena-Vázquez, Fernando Ortiz-Márquez, Teresa Ramírez-García, Pablo Cabezudo-García, Aimara García-Studer, Arkaitz Mucientes-Ruiz, Jose Manuel Lisbona-Montañez, Paula Borregón-Garrido, Patricia Ruiz-Limón, Rocío Redondo-Rodríguez, Sara Manrique-Arija, Laura Cano-García, Pedro J. Serrano-Castro, Antonio Fernández-Nebro
23 July 2024
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial Claudia Kedor, Jacqueline Detert, Rolf Rau, Siegfried Wassenberg, Joachim Listing, Pascal Klaus, Tanja Braun, Walter Hermann, Stefan Markus Weiner, Frank Buttgereit, Gerd R Burmester
11 January 2024
Health inequities and societal costs for patients with fibromyalgia and their spouses: a Danish cohort study Kirstine Amris, Rikke Ibsen, Pernille Hurup Duhn, Judi Olsen, Karoline Lolk, Jakob Kjellberg, Lars Erik Kristensen
2 February 2024